Proline

Proline

SCHEMBL4391659

N[C@@H](CS)C(=O)O.O=C(O)[C@@H]1CCCN1.O=C(O)[C@@H]1CCCN1.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Proline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.52
SLC7A11 Q9UPY5 1/20 0.52
CPN1 P15169 4/20 0.40
CPB2 Q96IY4 4/20 0.40
NOS2 P35228 2/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
MEN1 O00255 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
ANPEP P15144 2/20 0.35
ENPEP Q07075 1/20 0.35
PRCP P42785 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proline SCHEMBL15050063 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL51270 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL28759471 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL15049946 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL1298202 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL51269 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL27699077 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL4398351 0.94 PTGS1 (0.46) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL1675268 0.94 PTGS1 (0.46) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL7204958 0.94 PTGS1 (0.46) PTGS1SLC7A11CPN1CPB2NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632235-B1 System and method for measuring cardiac output via thermal dilution using an implantable medical device with an external ultrasound power delivery system PACESETTER, INC. (US) 2009-12-15 US disclosed
US-20090082266-A1 CONJUGATE OF WATER-SOLUBLE HYALURONIC ACID MODIFICATION PRODUCT WITH GLP-A ANALOGUE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-03-26 US disclosed
EP-1857467-A1 CONJUGATE OF WATER-SOLUBLE MODIFIED HYALURONIC ACID AND GLP-1 ANALOGUE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082266-A1 CONJUGATE OF WATER-SOLUBLE HYALURONIC ACID MODIFICATION PRODUCT WITH GLP-A ANALOGUE GLP1R, IAPP, GIPR PTGS1 529/4885SLC7A11 471/4885CPN1 2479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.